Amalgamated Bank Vbi Vaccines Inc Transaction History

Amalgamated Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.29 - $0.64 $1,295 - $2,859	-4,468 Reduced 18.42%	19,784 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.66 - $1.81 $3,699 - $10,146	-5,606 Reduced 18.78%	24,252 $20,000
Q1 2022 Jun 30, 2022	SELL	$1.27 - $2.47 $2,896 - $5,634	-2,281 Reduced 7.1%	29,858 $50,000
Q4 2021 Feb 15, 2022	SELL	$2.21 - $3.22 $464 - $676	-210 Reduced 0.65%	32,139 $75,000
Q3 2021 Oct 29, 2021	SELL	$2.8 - $3.72 $4,970 - $6,603	-1,775 Reduced 5.2%	32,349 $101,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $22,751 - $36,349	8,717 Added 34.31%	34,124 $114,000
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $2,425 - $3,948	1,128 Added 4.65%	25,407 $69,000
Q3 2020 Oct 30, 2020	SELL	$2.77 - $6.17 $1,470 - $3,276	-531 Reduced 2.14%	24,279 $69,000
Q2 2020 Aug 10, 2020	BUY	$0.87 - $3.13 $2,633 - $9,474	3,027 Added 13.9%	24,810 $77,000
Q1 2020 May 13, 2020	BUY	$0.73 - $1.91 $4,676 - $12,235	6,406 Added 41.66%	21,783 $21,000
Q4 2019 Feb 13, 2020	BUY	$0.48 - $1.38 $457 - $1,315	953 Added 6.61%	15,377 $21,000
Q3 2019 Nov 13, 2019	SELL	$0.47 - $1.05 $42 - $94	-90 Reduced 0.62%	14,424 $7,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $9,434 - $30,769	14,514 New	14,514 $17,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.